上海谊众拟3000万元至3500万元回购股份，公司股价年内涨46.62%

Group 1 - The company Shanghai Yizhong announced a share repurchase plan with a total amount between 30 million and 35 million yuan, at a maximum price of 106.08 yuan per share, which is 81.24% higher than the current price of 58.53 yuan [1] - The company's stock price has increased by 46.62% year-to-date [1] - Shanghai Yizhong specializes in the research and industrialization of modified new anti-tumor drugs, with its main revenue source being 99.84% from injectable paclitaxel polymer micelles [1] Group 2 - As of June 30, the number of shareholders for Shanghai Yizhong increased by 6.14% to 6,521, while the average circulating shares per person decreased by 5.78% to 31,698 shares [2] - For the first half of 2025, Shanghai Yizhong reported a revenue of 160 million yuan, representing a year-on-year growth of 31.48%, and a net profit attributable to shareholders of 38.0038 million yuan, up 10.13% year-on-year [2] - The company has distributed a total of 92.232 million yuan in dividends since its A-share listing [3]